|
|
|
|
Science Sparks @ ACTREC
|
 20 January 2025 |
Vol. No. 14 ; Issue No.666 |
|
|
Publications
|
|
1. Kumar B, Mittal P, Gupta A, Mulani J, Bhajbhuje R, Kannan S, Jain J, Chopra S (2025). Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective study. Brachytherapy.
2. Sundararajan R, Hegde SR, Panda AK, Christie J, Gadewal N, Venkatraman P (2025). Loss of correlated proteasomal subunit expression selectively promotes the 20SHigh state which underlies luminal breast tumorigenicity. Communications Biology. 8(1): 55.
3. Singh AG, Sinha S, Shetty R, Joshi P, Nair SV, Chaturvedi P (2025). Impact of Local Extent of Tumor on the Survival Outcomes for Surgically Treated Tongue Cancers. Head Neck.
4.
Gandhi AK, Chopra S, Rastogi M, Mallick I, Cruz MC, Yasuda K, Sum YY, Nagata Y, Wu HG, Prajogi GB, Kodrat H, Ma M, Nisar A, Chitapanarux I (2025). Multicentric Cross-Sectional Survey to Assess the Variation of Fractionation Strategies Used in the Management of Head and Neck Cancers in the Asian Region (INNOCENCE-ASIA). JCO Global Oncology.
|
|
|
|
|
|
|
Video of the Week
|
|
| From Synthetic Insights to ‘Au-Naturel’: IL-9 in T- Cell Therapy |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2016, FDA approved a liquid biopsy test, a companion diagnostic test called cobas EGFR Mutation Test v2.
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
